Format
Sort by
Items per page

Send to

Choose Destination

Best matches for O’Donnell JL[au]:

P-value. What value? O'Donnell JL et al. Intern Med J. (2018)

Management of Gout in a Hospital Setting: A Lost Opportunity. Wright S et al. J Rheumatol. (2017)

Evolve osteoporosis and other guidelines avoiding cognitive bias. O'Donnell JL et al. Intern Med J. (2016)

Search results

Items: 1 to 50 of 69

1.

Revealing biases in the sampling of ecological interaction networks.

de Aguiar MAM, Newman EA, Pires MM, Yeakel JD, Boettiger C, Burkle LA, Gravel D, Guimarães PR Jr, O'Donnell JL, Poisot T, Fortin MJ, Hembry DH.

PeerJ. 2019 Sep 2;7:e7566. doi: 10.7717/peerj.7566. eCollection 2019.

2.

A Pilot Randomized Controlled Double-Blind Trial of High- Versus Low-Dose Weekly Folic Acid in People With Rheumatoid Arthritis Receiving Methotrexate.

Stamp LK, OʼDonnell JL, Frampton C, Drake J, Zhang M, Barclay M, Chapman PT.

J Clin Rheumatol. 2019 Oct;25(7):284-287. doi: 10.1097/RHU.0000000000000848.

PMID:
30001258
3.

Practice Change From Intermittent Medication Boluses to Bolusing From a Continuous Infusion in Pediatric Critical Care: A Quality Improvement Project.

Hochstetler JL, Thompson AJ, Ball NM, Evans MC, Frame SC, Haney AL, Little AK, O'Donnell JL, Rickett BM, Mack EH.

Pediatr Crit Care Med. 2018 Jun;19(6):572-577. doi: 10.1097/PCC.0000000000001549.

PMID:
29652752
4.

Natural endocrine profiles of the group-living skunk anemonefish Amphiprion akallopisos in relation to their size-based dominance hierarchy.

Mills SC, O'Donnell JL, Bernardi G, Beldade R.

J Fish Biol. 2018 Mar;92(3):773-789. doi: 10.1111/jfb.13559.

PMID:
29537093
5.

P-value. What value?

O'Donnell JL.

Intern Med J. 2018 Mar;48(3):241-244. doi: 10.1111/imj.13723. No abstract available.

PMID:
29512327
6.

Management of Gout in a Hospital Setting: A Lost Opportunity.

Wright S, Chapman PT, Frampton C, O'Donnell JL, Raja R, Stamp LK.

J Rheumatol. 2017 Oct;44(10):1493-1498. doi: 10.3899/jrheum.170387. Epub 2017 Aug 1.

PMID:
28765252
7.

Spatial distribution of environmental DNA in a nearshore marine habitat.

O'Donnell JL, Kelly RP, Shelton AO, Samhouri JF, Lowell NC, Williams GD.

PeerJ. 2017 Feb 28;5:e3044. doi: 10.7717/peerj.3044. eCollection 2017.

8.

CLINICAL PATHOLOGIC CORRELATION OF SARCOIDOSIS-ASSOCIATED MULTIFOCAL CHORIORETINITIS IN AN ELDERLY PATIENT.

Saleh MGA, OʼDonnell JL, Davis RP, Wilson D, Lin P.

Retin Cases Brief Rep. 2019 Spring;13(2):154-157. doi: 10.1097/ICB.0000000000000547. Review.

PMID:
28145942
9.

A framework for inferring biological communities from environmental DNA.

Shelton AO, O'Donnell JL, Samhouri JF, Lowell N, Williams GD, Kelly RP.

Ecol Appl. 2016 Sep;26(6):1645-1659. doi: 10.1890/15-1733.1.

PMID:
27755698
10.

Evolve osteoporosis and other guidelines avoiding cognitive bias.

O'Donnell JL.

Intern Med J. 2016 Oct;46(10):1129-1133. doi: 10.1111/imj.13212. No abstract available.

PMID:
27734619
11.

Genetic signatures of ecological diversity along an urbanization gradient.

Kelly RP, O'Donnell JL, Lowell NC, Shelton AO, Samhouri JF, Hennessey SM, Feist BE, Williams GD.

PeerJ. 2016 Sep 13;4:e2444. doi: 10.7717/peerj.2444. eCollection 2016.

12.

Incidence of anti-neutrophil cytoplasmic antibody-associated vasculitis before and after the February 2011 Christchurch Earthquake.

Farquhar HJ, McGettigan B, Chapman PT, O'Donnell JL, Frampton C, Stamp LK.

Intern Med J. 2017 Jan;47(1):57-61. doi: 10.1111/imj.13246.

PMID:
27572474
13.

Indexed PCR Primers Induce Template-Specific Bias in Large-Scale DNA Sequencing Studies.

O'Donnell JL, Kelly RP, Lowell NC, Port JA.

PLoS One. 2016 Mar 7;11(3):e0148698. doi: 10.1371/journal.pone.0148698. eCollection 2016.

14.

Variation in partner benefits in a shrimp-sea anemone symbiosis.

McKeon CS, O'Donnell JL.

PeerJ. 2015 Nov 19;3:e1409. doi: 10.7717/peerj.1409. eCollection 2015.

15.

Association between environmental exposures and granulomatosis with polyangiitis in Canterbury, New Zealand.

Stamp LK, Chapman PT, Francis J, Beckert L, Frampton C, Watts RA, O'Donnell JL.

Arthritis Res Ther. 2015 Nov 24;17:333. doi: 10.1186/s13075-015-0852-6.

16.

Assessing vertebrate biodiversity in a kelp forest ecosystem using environmental DNA.

Port JA, O'Donnell JL, Romero-Maraccini OC, Leary PR, Litvin SY, Nickols KJ, Yamahara KM, Kelly RP.

Mol Ecol. 2016 Jan;25(2):527-41. doi: 10.1111/mec.13481. Epub 2015 Dec 24.

17.

Comparison of two plasma urate assays in patients receiving vitamin C supplementation.

Sies CW, Florkowski CM, Frampton CM, O'Donnell JL, Chapman PT, Stamp LK.

Pathology. 2014 Jun;46(4):333-5. doi: 10.1097/PAT.0000000000000095.

PMID:
24798153
18.

Biotinylation of ANCA target antigen improves assay performance for PR3-ELISA but not MPO-ELISA.

Hayman MW, Slade CA, Spellerberg MB, O'Donnell JL.

Pathology. 2013 Aug;45(5):525-7. doi: 10.1097/PAT.0b013e3283639bdc. No abstract available.

PMID:
23842044
19.

Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial.

Stamp LK, O'Donnell JL, Frampton C, Drake JM, Zhang M, Chapman PT.

Arthritis Rheum. 2013 Jun;65(6):1636-42. doi: 10.1002/art.37925.

20.

Cardiovascular morbidity in rheumatoid arthritis patients in North Canterbury, New Zealand 1999-2008.

Khan EA, Stamp LK, O'Donnell JL, Chapman PT.

Int J Rheum Dis. 2013 Feb;16(1):19-23. doi: 10.1111/1756-185x.12008. Epub 2012 Oct 19.

PMID:
23441768
21.

Comparison of the 2010 American College of Rheumatology/European League Against Rheumatism and the 1987 American Rheumatism Association classification criteria for rheumatoid arthritis in an early arthritis cohort in New Zealand.

Raja R, Chapman PT, O'Donnell JL, Ipenburg J, Frampton C, Hurst M, Stamp LK.

J Rheumatol. 2012 Nov;39(11):2098-103. doi: 10.3899/jrheum.120226. Epub 2012 Sep 15.

PMID:
22984270
22.

Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practice.

Stamp LK, Barclay ML, O'Donnell JL, Zhang M, Drake J, Frampton C, Chapman PT.

Rheumatology (Oxford). 2012 Sep;51(9):1670-6. doi: 10.1093/rheumatology/kes091. Epub 2012 Apr 26.

PMID:
22539486
23.

Wegener's granulomatosis: treatment and survival characteristics in a high-prevalence southern hemisphere region.

Khan AR, Chapman PT, Stamp LK, Wells JE, O'Donnell JL.

Intern Med J. 2012 Apr;42(4):e23-6. doi: 10.1111/j.1445-5994.2011.02700.x.

PMID:
22498132
24.

The Christchurch earthquake--providing a rheumatology service during a natural disaster.

Stamp LK, Ipenburg J, Hurst M, O'Donnell JL, Raja R, Drake J, Chapman PT.

Clin Rheumatol. 2012 Apr;31(4):723-5. doi: 10.1007/s10067-011-1913-0. Epub 2011 Dec 27.

PMID:
22200815
25.

Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritis.

Stamp LK, Barclay ML, O'Donnell JL, Zhang M, Drake J, Frampton C, Chapman PT.

J Rheumatol. 2011 Dec;38(12):2540-7. doi: 10.3899/jrheum.110481. Epub 2011 Oct 1.

PMID:
21965639
26.

Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.

Stamp LK, Barclay ML, O'Donnell JL, Zhang M, Drake J, Frampton C, Chapman PT.

Clin Pharmacol Ther. 2011 Sep;90(3):392-8. doi: 10.1038/clpt.2011.113. Epub 2011 Jul 27.

PMID:
21796116
27.
28.

Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment.

Stamp LK, O'Donnell JL, Zhang M, James J, Frampton C, Barclay ML, Chapman PT.

Arthritis Rheum. 2011 Feb;63(2):412-21. doi: 10.1002/art.30119.

29.

Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate.

Stamp LK, Chapman PT, O'Donnell JL, Zhang M, James J, Frampton C, Barclay ML, Kennedy MA, Roberts RL.

Pharmacogenet Genomics. 2010 Jun;20(6):367-76. doi: 10.1097/FPC.0b013e3283398a71.

PMID:
20386493
30.

Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy.

Stamp LK, O'Donnell JL, Chapman PT, Zhang M, James J, Frampton C, Barclay ML.

Arthritis Rheum. 2010 Feb;62(2):359-68. doi: 10.1002/art.27201.

31.

Lack of association between elevated mean red cell volume and haematological toxicity in patients receiving long-term methotrexate for rheumatoid arthritis.

White DH, Chapman PT, O'Donnell JL, James J, Frampton C, Stamp LK.

Intern Med J. 2010 Aug;40(8):561-5. doi: 10.1111/j.1445-5994.2009.02059.x. Epub 2009 Oct 7.

PMID:
19811562
32.

Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.

Stamp LK, O'Donnell JL, Chapman PT, Zhang M, Frampton C, James J, Barclay ML.

Arthritis Rheum. 2009 Aug;60(8):2248-56. doi: 10.1002/art.24653.

33.

Lack of association between HLA-G 14 bp insertion/deletion polymorphism and response to long-term therapy with methotrexate response in rheumatoid arthritis.

Stamp LK, O'Donnell JL, Chapman PT, Barclay ML, Kennedy MA, Frampton CM, Roberts RL.

Ann Rheum Dis. 2009 Jan;68(1):154-5. doi: 10.1136/ard.2008.089383. No abstract available.

PMID:
19088262
34.

Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis.

Dalrymple JM, Stamp LK, O'Donnell JL, Chapman PT, Zhang M, Barclay ML.

Arthritis Rheum. 2008 Nov;58(11):3299-308. doi: 10.1002/art.24034.

35.

Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritis.

Hollis-Moffatt JE, Merriman ME, Rodger RA, Rowley KA, Chapman PT, Dalbeth N, Gow PJ, Harrison AA, Highton J, Jones PB, O'Donnell JL, Stamp LK, Merriman TR.

Ann Rheum Dis. 2009 Aug;68(8):1340-4. doi: 10.1136/ard.2008.090142. Epub 2008 Jul 22.

PMID:
18647855
36.

Leflunomide-associated infections in rheumatoid arthritis.

Jenks KA, Stamp LK, O'Donnell JL, Savage RL, Chapman PT.

J Rheumatol. 2007 Nov;34(11):2201-3. Epub 2007 Oct 15.

PMID:
17937473
37.

Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis.

McKinney C, Merriman ME, Chapman PT, Gow PJ, Harrison AA, Highton J, Jones PB, McLean L, O'Donnell JL, Pokorny V, Spellerberg M, Stamp LK, Willis J, Steer S, Merriman TR.

Ann Rheum Dis. 2008 Mar;67(3):409-13. Epub 2007 Jun 29.

PMID:
17604289
38.

Antineutrophil cytoplasmic antibody measurement: advantages and disadvantages of a capture PR3 ELISA and a direct PR3 ELISA.

O'Donnell JL, Hayman MW, Spellerberg MB, McLellan AD, Brooksbank K, Chapman PT, Stamp LK.

Pathology. 2007 Apr;39(2):258-63.

PMID:
17454758
39.

Emerging therapies in the long-term management of hyperuricaemia and gout.

Stamp LK, O'Donnell JL, Chapman PT.

Intern Med J. 2007 Apr;37(4):258-66. Review.

PMID:
17388867
40.

Wegener's granulomatosis in New Zealand: evidence for a latitude-dependent incidence gradient.

O'Donnell JL, Stevanovic VR, Frampton C, Stamp LK, Chapman PT.

Intern Med J. 2007 Apr;37(4):242-6.

PMID:
17388864
41.

Solution-phase structural characterization of supramolecular assemblies by molecular diffraction.

O'Donnell JL, Zuo X, Goshe AJ, Sarkisov L, Snurr RQ, Hupp JT, Tiede DM.

J Am Chem Soc. 2007 Feb 14;129(6):1578-85.

PMID:
17284002
42.

Supramolecular porphyrinic prisms: coordinative assembly and solution phase X-ray structural characterization.

Lee SJ, Mulfort KL, O'Donnell JL, Zuo X, Goshe AJ, Wesson PJ, Nguyen ST, Hupp JT, Tiede DM.

Chem Commun (Camb). 2006 Nov 28;(44):4581-3. Epub 2006 Oct 18.

PMID:
17082849
43.

Soluble human leukocyte antigen: a diagnostic indicator of rheumatoid arthritis?

Hayman MW, van Beijnen MT, Stamp LK, Spellerberg MB, O'Donnell JL.

J Immunol Methods. 2006 Aug 31;315(1-2):19-26. Epub 2006 Jul 20.

PMID:
16893550
44.

Oncological implications of hypoxia inducible factor-1alpha (HIF-1alpha) expression.

O'Donnell JL, Joyce MR, Shannon AM, Harmey J, Geraghty J, Bouchier-Hayes D.

Cancer Treat Rev. 2006 Oct;32(6):407-16. Epub 2006 Aug 4. Review.

PMID:
16889900
45.

Unicentric Castleman's disease: a surprising neck mass.

O'Donnell JL, Henry FP, Kavanagh E, Brennan P, Kay E, Murphy P, Kelly CJ.

Ir J Med Sci. 2006 Jan-Mar;175(1):79-80.

PMID:
16615239
46.

Liquid/liquid interface polymerized porphyrin membranes displaying size-selective molecular and ionic permeability.

O'Donnell JL, Thaitrong N, Nelson AP, Hupp JT.

Langmuir. 2006 Feb 14;22(4):1804-9.

PMID:
16460110
47.

Levels of the soluble forms of CD80, CD86, and CD83 are elevated in the synovial fluid of rheumatoid arthritis patients.

Hock BD, O'Donnell JL, Taylor K, Steinkasserer A, McKenzie JL, Rothwell AG, Summers KL.

Tissue Antigens. 2006 Jan;67(1):57-60.

PMID:
16451202
48.

The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region.

Gibson A, Stamp LK, Chapman PT, O'Donnell JL.

Rheumatology (Oxford). 2006 May;45(5):624-8. Epub 2005 Dec 20.

PMID:
16368729
49.

Association of the PTPN22 locus with rheumatoid arthritis in a New Zealand Caucasian cohort.

Simkins HM, Merriman ME, Highton J, Chapman PT, O'Donnell JL, Jones PB, Gow PJ, McLean L, Pokorny V, Harrison AA, Merriman TR.

Arthritis Rheum. 2005 Jul;52(7):2222-5. No abstract available.

50.

Prioritizing health-care funding.

O'Donnell JL, Smyth D, Frampton C.

Intern Med J. 2005 Jul;35(7):409-12.

PMID:
15958111

Supplemental Content

Loading ...
Support Center